Erlocip 150mg Tablet: Effective Treatment for Your Health

Erlocip 150mg Tablet

Uses:

• Advanced or metastatic non-small cell lung cancer (NSCLC).
• Advanced or metastatic pancreatic cancer, especially when previous therapy failed.

Therapeutic Effects:

• Prevents the activity of epidermal growth factor receptor (EGFR), a protein involved in the spread and growth of cancer cells.

Administration:

• Taken in combination with Gemcitabine to treat metastatic pancreatic cancer.
• Must be taken at least one hour before or two hours after food.
• Follow prescribed dosage schedule.

Safety Advice:

• Pregnancy: Not recommended during pregnancy unless advised by a doctor.
• Breastfeeding: Not recommended while breastfeeding.
• Lungs: Consult a doctor about potential effects on the lungs.
• Liver: Not recommended in patients with severe liver diseases.
• Alcohol: Consult a doctor about the safety of consuming alcohol.
• Driving: Do not drive if experiencing symptoms affecting concentration and reaction.

Interaction with Other Drugs:

• Inform the doctor about all medications, including prescribed, over-the-counter, nutritional supplements, and herbal products.

Side Effects:

• Serious: Persistent or severe diarrhea, eye pain, blurred vision, difficulty breathing, severe abdominal pain, liver failure.
• Common: Rash, loss of appetite, infection, headache, depression, nausea, mouth irritation, indigestion, hair loss, dry skin, itching, tiredness, abnormal liver function, inflammation around fingernail, acne, cracked skin, bleeding, reduced kidney function.

Word of Advice:

• Inform the doctor about vision problems, clotting disorders, sugar intolerance, cholesterol medication, and kidney/liver disorders.
• Avoid smoking while taking the medication.
• Not recommended for individuals below 18 years of age.

FAQs:

1. How should I take an Erlocip 150 mg tablet?
   • Take as prescribed by the doctor, at least one hour before or two hours after food, at a fixed time daily.
2. Does an Erlocip 150 mg tablet cause eye dryness?
   • Yes, it can cause eye dryness and conjunctivitis. Inform the doctor about vision problems.
3. Can I take an Erlocip 150 mg tablet during pregnancy?
   • Not recommended due to potential harm to the developing baby.
4. Can I smoke while taking the Erlocip 150 mg tablet?
   • Avoid smoking as it can decrease the effectiveness of the medication.
5. How long can I take an Erlocip 150 mg tablet?
   • Duration varies depending on the severity of the disease and doctor's prescription.
6. Can Erlocip 150 mg Tablet be used in kidney disorders?
   • Not recommended in kidney patients as it can worsen the condition.

Fact Box:

• Molecule name: Erlotinib
• Therapeutic class: Tyrosine kinase inhibitor
• Pharmacological class: Anti-Neoplastics
• Indications:
  • Advanced or metastatic non-small lung cancer (NSCLC).
  • Advanced or metastatic pancreatic cancer.

Tags: cancer_treatment, chemotherapy, oncology, tablets, erlocip, medicine